Adrenoleukodystrophy differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Adrenoleukodystrophy}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Adrenoleukodystrophy]]
{{CMG}}; {{AE}}
{{CMG}}; {{AE}}


Line 6: Line 6:


==Overview==
==Overview==
Adrenoleukodystrophy must be differentiated from [[Leigh syndrome]], [[Niemann-Pick]] disease type C, Infantile Refsum disease, [[Zellweger syndrome]], [[Pyruvate dehydrogenase deficiency]], [[Arginase deficiency]], Holocarboxylase synthetase deficiency, Glutaric aciduria type 1, [[Ataxia telangiectasia]], [[Pontocerebellar]] [[hypoplasias]], [[Metachromatic leukodystrophy]], [[Pelizaeus-Merzbacher]], [[Angelman syndrome]], [[Rett syndrome]], [[Lesch-Nyhan syndrome]], Miller-Dieker lissencephaly and Dopa-responsive [[dystonia]].


==Differential Diagnosis==
==Differential Diagnosis==
Adrenoleukodystrophy must be differentiated from other diseases that cause neurological manifestations in infants.
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! rowspan="2" |Diseases
! colspan="4" |Type of motor abnormality
! rowspan="2" |Clinical findings
! rowspan="2" |Laboratory findings and diagnostic tests
! rowspan="2" |Radiographic findings
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
!Spasticity
!Hypotonia
!Ataxia
!Dystonia
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Leigh syndrome]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
* Progressive [[psychomotor]] regression
* [[Seizures]]
* External [[ophthalmoplegia]]
* [[Lactic acidosis]]
* [[Vomiting]]
| style="background: #F5F5F5; padding: 5px;" |
* Increased [[lactate]] levels in [[blood]] and [[CSF]]
* Genetic testing 
| style="background: #F5F5F5; padding: 5px;" |
* MRI: abnormal [[white matter]] signal in the [[putamen]], [[basal ganglia]], and [[brainstem]] on T2 images
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Niemann-Pick]] disease type C
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
* Progressive [[neurodegeneration]]
* [[Hepatosplenomegaly]]
* Systemic involvement of [[liver]], [[spleen]], or [[lung]] preceedes [[neurologic]] symptoms
| style="background: #F5F5F5; padding: 5px;" |
* Abnormal [[liver]] function tests
* [[Fibroblast]] cell culture with filipin staining
| style="background: #F5F5F5; padding: 5px;" |
* MRI:
**[[Cerebral]] and [[cerebellar]] [[atrophy]]
**Thinning of the [[corpus callosum]]
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Infantile Refsum disease
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
* Abnormalities of the [[optic nerve]] and disc
* [[Retinitis pigmentosa]]
* [[Sensorineural]] hearing loss
* [[Hepatomegaly]] and [[cirrhosis]]
* [[Neurologic]] deterioration is slower than in [[Zellweger syndrome]] or ALD
| style="background: #F5F5F5; padding: 5px;" |Elevated plasma VLCFA levels
| style="background: #F5F5F5; padding: 5px; text-align: center;" |--
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Adrenoleukodystrophy]]
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
* [[Cognitive]] and behavioral abnormalities
* [[Adrenal insufficiency]]
* [[Hyperpigmented]] skin
* [[Gonadal dysfunction]]
* [[Neurologic]] deterioration progresses at a variable rate
| style="background: #F5F5F5; padding: 5px;" |
* Elevated plasma VLCFA levels
* Molecular [[genetic testing]] for mutations in the ABCD1 gene
| style="background: #F5F5F5; padding: 5px; text-align: center;" |--
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Zellweger syndrome]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
* [[Craniofacial]] dysmorphism
* [[Hepatomegaly]]
* Neonatal [[seizures]]
* Profound developmental delay
* [[MRI]] findings include [[cortical]] and [[white matter]] abnormalities
* [[Neurologic deterioration]] is rapid and infants rarely survive beyond six months of age
| style="background: #F5F5F5; padding: 5px;" |
* Elevated plasma VLCFA levels
* Elevated levels of [[phytanic acid]], pristanic acid, and pipecolic acid in plasma and [[fibroblasts]]
* Reduced plasmalogen in [[erythrocytes]]
* Molecular [[genetic]] testing for [[mutations]] in the PEX1 or PEX6 genes
| style="background: #F5F5F5; padding: 5px; text-align: center;" |--
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pyruvate dehydrogenase deficiency]]
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
* [[Lactic acidosis]]
* [[Seizures]]
* [[Intellectual disability]]
| style="background: #F5F5F5; padding: 5px;" |
* Elevated [[lactate]] and pyruvate levels in [[blood]] and CSF
* Abnormal PDH enzymatic activity in cultured fibroblasts
| style="background: #F5F5F5; padding: 5px; text-align: center;" |--
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Arginase deficiency]]
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
* [[Hyperammonemia]]
* [[Encephalopathy]]
* [[Respiratory alkalosis]]
| style="background: #F5F5F5; padding: 5px;" |
* Elevated [[ammonia]] level
* Elevated [[arginine]] level
| style="background: #F5F5F5; padding: 5px; text-align: center;" |--
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Holocarboxylase synthetase deficiency
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
* [[Ketoacidosis]]
* [[Dermatitis]]
* [[Alopecia]]
* [[Seizures]]
* [[Developmental delay]]
| style="background: #F5F5F5; padding: 5px;" |Elevated levels of:
* Beta-hydroxyisovalerate
* Beta-methylcrotonylglycine
* Beta-hydroxypropionate
* Methylcitrate
* Tiglylglycine
| style="background: #F5F5F5; padding: 5px; text-align: center;" |--
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Glutaric aciduria type 1
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |
* Episodes of [[metabolic decompensation]] and [[encephalopathy]] often precipitated by [[infection]] and [[fever]]
* Rarely presents in the newborn period
* Microencephalic [[macrocephaly]]
* [[Seizures]] (approximately 20 percent)
* [[Cognitive function]] is preserved
| style="background: #F5F5F5; padding: 5px;" |Elevated levels of:
* [[glutaric acid]]
* 3-hydroxyglutaric acid
| style="background: #F5F5F5; padding: 5px;" |
* MRI:
**[[Frontal]] and [[temporal]] [[atrophy]]
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Ataxia telangiectasia]]
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>+</nowiki>
| style="background: #F5F5F5; padding: 5px;" |<nowiki>-</nowiki>
| style="background: #F5F5F5; padding: 5px;" |
* Progressive [[cerebellar]] [[ataxia]]
* Abnormal eye movements
* [[Oculocutaneous]] [[telangiectasias]]
* Immune deficiency
* Increased risk of [[malignancy]]
| style="background: #F5F5F5; padding: 5px;" |
* Elevated serum alpha-fetoprotein level
* Low [[IgA]] and [[IgG]] levels
* [[Lymphopenia]]
* Genetic testing for [[mutation]] in the ATM gene
| style="background: #F5F5F5; padding: 5px; text-align: center;" |--
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pontocerebellar]] [[hypoplasias]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
* Progressive muscle [[atrophy]]
* [[Microcephaly]]
* [[Developmental delay]]
| style="background: #F5F5F5; padding: 5px;" |[[Genetic]] testing for PCH gene mutations
| style="background: #F5F5F5; padding: 5px;" |
* MRI :
**Small [[cerebellum]] and [[brainstem]] including the [[pons]]
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Metachromatic leukodystrophy]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
* Regression of motor skills
* [[Seizures]]
* [[Optic atrophy]]
* Reduced or absent [[deep tendon reflexes]]
* [[Intellectual disability]]
| style="background: #F5F5F5; padding: 5px;" |
* Deficient arylsulfatase A enzyme activity in [[leukocytes]] or cultured skin fibroblasts
| style="background: #F5F5F5; padding: 5px; text-align: center;" |--
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Pelizaeus-Merzbacher]]
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
* [[Nystagmus]]
* [[Cognitive impairment]]
* Onset in infancy
* Slowly progressive
* Language development may be normal
| style="background: #F5F5F5; padding: 5px;" |
* [[Genetic]] testing for [[mutations]] in PLP1 gene
| style="background: #F5F5F5; padding: 5px;" |
*MRI:
**[[White matter]] abnormalities
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Angelman syndrome]]
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
* Profound [[intellectual disability]]
* Postnatal [[microcephaly]]
* Typical abnormal behaviors (paroxysmal laughter, easily excitable)
| style="background: #F5F5F5; padding: 5px;" |
* Methylation studies and [[chromosome]] microarray to detect chromosome 15 anomalies and UBE3A mutations
| style="background: #F5F5F5; padding: 5px; text-align: center;" |--
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Rett syndrome]]
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
* Occurs almost exclusively in females
* Normal development during first six months followed by regression and loss of milestones
* Loss of speech capability
* Stereotypic hand movements
* [[Seizures]]
* [[Autistic]] features
| style="background: #F5F5F5; padding: 5px;" |
* Clinical diagnosis
* [[Genetic]] testing for MECP2 mutations
| style="background: #F5F5F5; padding: 5px; text-align: center;" |--
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Lesch-Nyhan syndrome]]
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
* [[Self-mutilating]] behavior
* [[Urinary]] stones due to [[hyperuricemia]]
| style="background: #F5F5F5; padding: 5px;" |
* Elevated [[uric acid]] level
* Abnormal enzymatic activity of HPRT in cultured fibroblasts
* [[Genetic]] testing for HPRT gene [[mutations]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |--
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Miller-Dieker lissencephaly
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
* [[Lissencephaly]]
* [[Microcephaly]]
* [[Dysmorphic]] features
* [[Seizures]]
* Failure to thrive
| style="background: #F5F5F5; padding: 5px;" |
* Cytogenetic testing for 17p13.3 microdeletion
| style="background: #F5F5F5; padding: 5px; text-align: center;" |--
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Dopa-responsive [[dystonia]]
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" |
* Onset in early childhood
* Symptoms worsen with [[fatigue]] and exercise
| style="background: #F5F5F5; padding: 5px;" |
* Positive response to a trial of [[levodopa]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |--
|}


==References==
==References==

Latest revision as of 18:50, 23 June 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.

Overview

Adrenoleukodystrophy must be differentiated from Leigh syndrome, Niemann-Pick disease type C, Infantile Refsum disease, Zellweger syndrome, Pyruvate dehydrogenase deficiency, Arginase deficiency, Holocarboxylase synthetase deficiency, Glutaric aciduria type 1, Ataxia telangiectasia, Pontocerebellar hypoplasias, Metachromatic leukodystrophy, Pelizaeus-Merzbacher, Angelman syndrome, Rett syndrome, Lesch-Nyhan syndrome, Miller-Dieker lissencephaly and Dopa-responsive dystonia.

Differential Diagnosis

Adrenoleukodystrophy must be differentiated from other diseases that cause neurological manifestations in infants.

Diseases Type of motor abnormality Clinical findings Laboratory findings and diagnostic tests Radiographic findings
Spasticity Hypotonia Ataxia Dystonia
Leigh syndrome - - + +
Niemann-Pick disease type C - - + +
  • Abnormal liver function tests
  • Fibroblast cell culture with filipin staining
Infantile Refsum disease - + + - Elevated plasma VLCFA levels --
Adrenoleukodystrophy + - - -
  • Elevated plasma VLCFA levels
  • Molecular genetic testing for mutations in the ABCD1 gene
--
Zellweger syndrome - + - - --
Pyruvate dehydrogenase deficiency + + + -
  • Elevated lactate and pyruvate levels in blood and CSF
  • Abnormal PDH enzymatic activity in cultured fibroblasts
--
Arginase deficiency + - - - --
Holocarboxylase synthetase deficiency - + - - Elevated levels of:
  • Beta-hydroxyisovalerate
  • Beta-methylcrotonylglycine
  • Beta-hydroxypropionate
  • Methylcitrate
  • Tiglylglycine
--
Glutaric aciduria type 1 - - - + Elevated levels of:
Ataxia telangiectasia - - + - --
Pontocerebellar hypoplasias - + - - Genetic testing for PCH gene mutations
Metachromatic leukodystrophy - + + -
  • Deficient arylsulfatase A enzyme activity in leukocytes or cultured skin fibroblasts
--
Pelizaeus-Merzbacher + - + -
Angelman syndrome - - + -
  • Methylation studies and chromosome microarray to detect chromosome 15 anomalies and UBE3A mutations
--
Rett syndrome + - - +
  • Occurs almost exclusively in females
  • Normal development during first six months followed by regression and loss of milestones
  • Loss of speech capability
  • Stereotypic hand movements
  • Seizures
  • Autistic features
  • Clinical diagnosis
  • Genetic testing for MECP2 mutations
--
Lesch-Nyhan syndrome + - - + --
Miller-Dieker lissencephaly + + - -
  • Cytogenetic testing for 17p13.3 microdeletion
--
Dopa-responsive dystonia + - - +
  • Onset in early childhood
  • Symptoms worsen with fatigue and exercise
  • Positive response to a trial of levodopa
--

References

Template:WH Template:WS